We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Corning
GLW
$123B
| $3.94M | 0.03% |
96,308
+50,822
| +112% | +$2.22M |
|
452
International Flavors & Fragrances
IFF
$19.5B
| $3.91M | 0.03% |
26,183
+14,602
| +126% | +$2.1M |
|
453
Manulife Financial
MFC
$73.2B
| $3.9M | 0.03% |
197,927
-288,564
| -59% | -$6.04M |
|
454
PACCAR
PCAR
$70.2B
| $3.83M | 0.03% |
64,350
+1,506
| +2% | +$92.3K |
|
455
O'Reilly Automotive
ORLY
$75.1B
| $3.82M | 0.03% |
101,130
+40,650
| +67% | +$1.46M |
|
456
Protagonist Therapeutics
PTGX
$8.72B
| $3.75M | 0.03% |
+83,646
| New | +$2.76M |
|
457
Under Armour
UAA
$3.02B
| $3.74M | 0.03% |
+18,978
| New | +$423K |
|
458
State Street
STT
$50.7B
| $3.71M | 0.03% |
45,139
-84,693
| -65% | -$7.15M |
|
459
Unilever
UL
$132B
| $3.67M | 0.03% |
55,719
+14,802
| +36% | +$984K |
|
460
Ameriprise Financial
AMP
$47.6B
| $3.65M | 0.03% |
14,682
-46,795
| -76% | -$11.8M |
|
461
Nu Skin
NUS
$250M
| $3.62M | 0.02% |
63,871
+30,296
| +90% | +$1.72M |
|
462
Snap
SNAP
$7.6B
| $3.61M | 0.02% |
52,982
+4,632
| +10% | +$278K |
|
463
D.R. Horton
DHI
$41.3B
| $3.59M | 0.02% |
39,723
-55,178
| -58% | -$5.18M |
|
464
GoDaddy
GDDY
$12.8B
| $3.57M | 0.02% |
41,063
+32,373
| +373% | +$2.7M |
|
465
Boston Scientific
BSX
$67.6B
| $3.55M | 0.02% |
83,117
-3,216
| -4% | -$135K |
|
466
Raymond James Financial
RJF
$33.3B
| $3.5M | 0.02% |
40,467
+36,468
| +912% | +$3.18M |
|
|
EVA
467
DELISTED
Enviva Inc.
EVA
| $3.48M | 0.02% |
66,496
+38,785
| +140% | +$1.91M |
|
|
BNY
468
Bank of New York Mellon
BNY
$107B
| $3.48M | 0.02% |
67,992
-164,250
| -71% | -$8.22M |
|
469
Progressive
PGR
$125B
| $3.45M | 0.02% |
35,129
-58,117
| -62% | -$5.75M |
|
|
HOME
470
DELISTED
At Home Group Inc.
HOME
| $3.44M | 0.02% |
+93,286
| New | +$3.18M |
|
471
Yeti Holdings
YETI
$3.86B
| $3.43M | 0.02% |
37,369
+6,825
| +22% | +$593K |
|
472
HubSpot
HUBS
$11.4B
| $3.42M | 0.02% |
5,878
+265
| +5% | +$138K |
|
473
Phillips 66
PSX
$83.3B
| $3.34M | 0.02% |
38,913
-1,125
| -3% | -$95K |
|
|
WBA
474
DELISTED
Walgreens Boots Alliance
WBA
| $3.31M | 0.02% |
62,928
-10,313
| -14% | -$555K |
|
475
Blackstone
BX
$106B
| $3.3M | 0.02% |
34,000
-31
| -0.1% | -$2.75K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.